Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes.
Normal human melanocytes have been shown to respond to the signal peptide endothelin by increased proliferation and melanin formation. Contradictory findings, however, have been reported about which of the two endothelin receptors (EDNRA or EDNRB) is expressed in normal melanocytes and melanoma cells. Moreover it was not clear whether malignant cells differ from their normal precursors in this respect. Screening a melanocyte cDNA library for genes downregulated in melanomas identified clones specific for EDNRB. Northern blots proved that the corresponding mRNA is generally expressed in cultures of human cutaneous melanocytes and congenital melanocytic nevus cells. In 16 of 17 melanoma cell lines, however, the expression of EDNRB mRNA was strongly downregulated. EDNRA was only weakly expressed and detectable by northern blotting in 12 of 17 cultures of benign melanocytic cells and four of 17 melanoma cell lines. Nested reverse transcriptase-polymerase chain reaction proved several melanoma cell lines to be completely negative for EDNRA expression. Gene deletion as the cause of missing endothelin receptor expression was ruled out by genomic Southern blots. Receptor binding assays confirmed RNA data revealing 1.6 x 105 endothelin-1 binding sites per cell for a melanocyte culture and between 8.7 x 104 and 400 sites per cell for melanoma cell lines. Expression of pigmentation genes coding for tyrosinase, TRP-1 and TRP-2 correlated positively with that of EDNRB but negatively with EDNRA expression. EDNRB but not EDNRA expression is therefore typical for melanocytic cells, and downregulation of EDNRB seems to be an important characteristic of melanoma cells possibly related to malignancy or apoptosis.
Eberle
J
J
Department of Dermatology, University Medical Center Benjamin Franklin, The Free University of Berlin, Germany.
Weitmann
S
S
Thieck
O
O
Pech
H
H
Paul
M
M
Orfanos
C E
CE
D015152:Blotting, Northern; D002454:Cell Differentiation / Q000235:genetics; D015536:Down-Regulation; D017353:Gene Deletion; D015870:Gene Expression; D015723:Gene Library; D006801:Humans; D019746:Intramolecular Oxidoreductases / Q000235:genetics / Q000502:physiology; D008544:Melanocytes / Q000737:chemistry / Q000378:metabolism; D008545:Melanoma / Q000473:pathology*; D008562:Membrane Glycoproteins; D014442:Monophenol Monooxygenase / Q000235:genetics; D010088:Oxidoreductases; D011506:Proteins / Q000235:genetics / Q000502:physiology; D012333:RNA, Messenger / Q000032:analysis; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D017466:Receptors, Endothelin / Q000235:genetics / Q000502:physiology*; D014407:Tumor Cells, Cultured
D008562:Membrane Glycoproteins; D011506:Proteins; D012333:RNA, Messenger; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D017466:Receptors, Endothelin; D010088:Oxidoreductases; C489799:TYRP1 protein, human; C064056:tyrosinase-related protein-1; D014442:Monophenol Monooxygenase; D019746:Intramolecular Oxidoreductases; C042501:dopachrome isomerase